Federal recipient
Inhibikase Therapeutics, Inc.
$0 committed in FY2025 — no awards to them that year.See all years →Jump to FY2024 →
- District
- GA-11
- Location
- Suite 1927, 3350, Riverwood Parkway South East, Atlanta, GA, 30339
- UEI
- E5PSKKJUHEW4
- DUNS
- 828325899
- Also known as
- Inhibikase Therapeutics Inc., Inhibikase Therapeutics LLC
What budget it comes from
The Treasury accounts Inhibikase Therapeutics, Inc.'s awards draw on. Dollars committed on awards that span more than one account are split evenly across them.
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Health and Human Services
075-0886
$6.6M
2 awards
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services
075-0885
$3.5M
1 awards
Committed by fiscal year
Dollars committed to Inhibikase Therapeutics, Inc., per fiscal year (FY2018–FY2024).
How to read these numbers
- Committed to this recipient
The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.
- Lifetime vs. a single year
The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.
- “Active in FY X”
A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.
- Names come raw
Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.
- The colored bars
Every bar on this page splits by how the money moves:
Direct payments
